Plasmin: Phase I data

Data from 78 evaluable patients in an open-label, dose-escalation, U.S. Phase I trial showed that single doses of 25-175 mg catheter-delivered

Read the full 214 word article

How to gain access

Continue reading with a
two-week free trial.